← Back to Akzo Nobel India Ltd. overview
Akzo Nobel India Ltd. — 10-Year Financials
Annual P&L, balance sheet, and key ratios from public BSE/NSE filings.
| Period | Revenue | Net Profit | EPS (₹) | Total Assets | Shareholder Equity | ROE (%) | ROCE (%) | D/E | Net Margin (%) |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹4,065 cr | ₹430 cr | ₹94.31 | ₹2,903 cr | ₹1,330 cr | 32.29% | 41.59% | 0.05x | 10.57% |
| FY2024 | ₹3,937 cr | ₹427 cr | ₹93.68 | ₹2,904 cr | ₹1,330 cr | 32.08% | 41.95% | 0.05x | 10.84% |
| FY2023 | ₹3,777 cr | ₹335 cr | ₹73.58 | ₹2,741 cr | ₹1,316 cr | 25.46% | 33.67% | 0.05x | 8.87% |
| FY2022 | ₹3,109 cr | ₹290 cr | ₹63.7 | ₹2,592 cr | ₹1,260 cr | 23.03% | 28.46% | 0.06x | 9.33% |
Revenue: Total income from operations (₹ crore).
EPS: Earnings per share (₹), basic.
ROE: Net profit / average shareholder equity.
ROCE: EBIT / capital employed.
D/E: Total debt / shareholder equity.
Net Margin: Net profit as a % of revenue.
All figures sourced from public BSE/NSE filings. Ratios are pre-computed estimates and may differ from primary filings due to rounding.
Educational content — not investment adviceAll financial data is sourced from public filings and shown here for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing on this page constitutes a recommendation or solicitation to transact in any security. All data is at least 90 days old. Past performance is not indicative of future results.